Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy.

Cardiac amyloidosis Heart failure Resynchronization therapy Right ventricular pacing Case report

Journal

European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 28 11 2019
revised: 02 01 2020
accepted: 24 03 2020
entrez: 4 7 2020
pubmed: 4 7 2020
medline: 4 7 2020
Statut: epublish

Résumé

Cardiac amyloidosis involvement is associated with a detrimental outcome including frequent arrhythmias, heart failure, and conduction disturbances which may need permanent pacing. We report two cases of patients with transthyretin amyloidosis (ATTR) who developed heart failure and depressed left ventricular ejection fraction (LVEF) following permanent right ventricular (RV) pacing but highly responded to cardiac resynchronization therapy (CRT). The impact of RV pacing and CRT in cardiac amyloidosis is not known. In our cases, the detrimental effect of permanent RV pacing on left ventricular (LV) systolic function and heart failure symptoms was suggested by both permanent RV pacing mediated functional and LV function decline and LV systolic dysfunction reversal following CRT along with QRS width reduction. Whether cardiac resynchronization should be readily recommended in ATTR patients who need ventricular pacing whatever the LVEF deserves further investigation.

Sections du résumé

BACKGROUND BACKGROUND
Cardiac amyloidosis involvement is associated with a detrimental outcome including frequent arrhythmias, heart failure, and conduction disturbances which may need permanent pacing.
CASES SUMMARY METHODS
We report two cases of patients with transthyretin amyloidosis (ATTR) who developed heart failure and depressed left ventricular ejection fraction (LVEF) following permanent right ventricular (RV) pacing but highly responded to cardiac resynchronization therapy (CRT).
DISCUSSION CONCLUSIONS
The impact of RV pacing and CRT in cardiac amyloidosis is not known. In our cases, the detrimental effect of permanent RV pacing on left ventricular (LV) systolic function and heart failure symptoms was suggested by both permanent RV pacing mediated functional and LV function decline and LV systolic dysfunction reversal following CRT along with QRS width reduction. Whether cardiac resynchronization should be readily recommended in ATTR patients who need ventricular pacing whatever the LVEF deserves further investigation.

Identifiants

pubmed: 32617488
doi: 10.1093/ehjcr/ytaa088
pii: ytaa088
pmc: PMC7319833
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1-5

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Heart Rhythm. 2008 Feb;5(2):235-40
pubmed: 18242546
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2427-2432
pubmed: 31515942
Acta Cardiol. 2013 Jun;68(3):335-7
pubmed: 23882883
Arch Cardiovasc Dis. 2013 Oct;106(10):528-40
pubmed: 24070600
Amyloid. 2017 Sep;24(3):194-204
pubmed: 28758793
Int J Cardiol. 2016 Nov 1;222:562-568
pubmed: 27513652
Amyloid. 2016 Sep;23(3):194-202
pubmed: 27647161

Auteurs

David Aouate (D)

Cardiology Department, GCS-Groupement des Hôpitaux de l'Institut Catholique Lillois/Faculté de médecine et de maïeutique, UCLille, F-59000 Lille, France.

Aymeric Menet (A)

Cardiology Department, GCS-Groupement des Hôpitaux de l'Institut Catholique Lillois/Faculté de médecine et de maïeutique, UCLille, F-59000 Lille, France.

Dimitri Bellevre (D)

Department of Nuclear Medicine, UF 5881, Groupement des Hôpitaux de l'Institut Catholique de Lille, Hôpital Saint Philibert rue du grand but, 59160 Lomme, France.

Thibaud Damy (T)

Department of Cardiology, Referral Center for Cardiac Amyloidosis, Mondor Amyloidosis Network, GRC Amyloid Research Institute, Clinical Investigation Center 006, DHU A-TVB INSERM U955 all at CHU Henri Mondor, UPEC, Créteil, France.

Sylvestre Marechaux (S)

Cardiology Department, GCS-Groupement des Hôpitaux de l'Institut Catholique Lillois/Faculté de médecine et de maïeutique, UCLille, F-59000 Lille, France.

Classifications MeSH